2. Peptides
  3. Peptide and Derivatives
  4. Antimicrobial Peptides

Antimicrobial Peptides

Custom Peptide Synthesis

Antimicrobial Peptides (526):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-A0248
    Polymyxin B Sulfate 1405-20-5
    Polymyxin B Sulfate is a potent antibacterial agent and a relatively toxic antibiotic. Polymyxin B Sulfate also is a antiendotoxin agent. Polymyxin B Sulfate shows endotoxin-neutralizing properties can be used as adjunctive research in gram-negative sepsis. Polymyxin B Sulfate shows antibacterial activities in vitro and in vivo.
    Polymyxin B Sulfate
  • HY-P1222
    LL-37, human 154947-66-7 99.60%
    LL-37, human is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity. LL-37, human could help protect the cornea from infection and modulates wound healing.
    LL-37, human
  • HY-B0990
    Thiostrepton 1393-48-2 99.80%
    Thiostrepton is a thiazole antibiotic which selectively inhibits FOXM1. FOXM1 binds to YAP/TEAD complex. YAP/TEAD/FOXM1 complex binding at regulatory regions of genes governing cell cycle may impact cell proliferation.
    Thiostrepton
  • HY-B0108
    Daptomycin 103060-53-3 99.90%
    Daptomycin is a lipopeptide antibiotic with rapid in vitro bactericidal activity against gram-positive organisms.
    Daptomycin
  • HY-P1607
    Nisin 1414-45-5
    Nisin is a bacteriocin produced by a group of Gram-positive bacteria that belongs to Lactococcus and Streptococcus species. Nisin has antibacterial and anti-inflammatory activity.
    Nisin
  • HY-P10304A
    Cyclo(Arg-Pro) TFA 98.04%
    Cyclo(Arg-Pro) (Cyclo(Pro-Arg)) TFA is a chitinase inhibitor. Cyclo(Arg-Pro) TFA inhibits cell separation of Saccharomyces cerevisiae, without affecting its growth. Cyclo(Arg-Pro) TFA inhibits the morphological change of Candida albicans from yeast form to filamentous form.
    Cyclo(Arg-Pro) TFA
  • HY-P10233A
    SAAP 148 TFA 99.72%
    SAAP 148 TFA is an antimicrobial and antibiofilm agent, and exhibits inhibitory efficacy against antibiotic-resistant pathogens, with LC50 of 0.8-12.8 μM.
    SAAP 148 TFA
  • HY-P0230
    Teixobactin 1613225-53-8
    Teixobactin is a potent antibiotic. Teixobactin shows antibacterial activity for gram-negative bacteria. Teixobactin inhibits cell wall synthesis by binding to a highly conserved motif of lipid II and lipid III.
    Teixobactin
  • HY-P1975
    Aureobasidin A 127785-64-2 99.36%
    Aureobasidin A (Basifungin) is a cyclic peptide antibiotic with oral activity. Aureobasidin A is an inhibitor of inositol phosphorylated ceramide synthetase AUR1. Aureobasidin A has antifungal and antiparasitic activity.
    Aureobasidin A
  • HY-P0163
    Gramicidin 1405-97-6 ≥98.0%
    Gramicidin is an antimicrobial peptide assembling as channels in membranes and increasing their permeability towards cations.
    Gramicidin
  • HY-P0233
    Melittin 20449-79-0 99.78%
    Melittin is a PLA2 activator, stimulates the activity of the low molecular weight PLA2, while it does not the increase activity of the high molecular weight PLA2.
    Melittin
  • HY-P1222A
    LL-37, human TFA 99.78%
    LL-37, human TFA is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity. LL-37, human TFA could help protect the cornea from infection and modulates wound healing.
    LL-37, human TFA
  • HY-106268A
    Larazotide acetate 881851-50-9 99.74%
    Larazotide acetate is a peptide which is an orally active zonulin antagonist. Larazotide acetate shows antiviral activity to varicella-zoster virus (VZV) with EC50s of 44.14 and 59.06 μM for strain OKA and 07-1, respectively. Larazotide acetate can be used for the research of celiac disease and infection.
    Larazotide acetate
  • HY-106783
    Polymyxin B nonapeptide 86408-36-8 99.82%
    Polymyxin B nonapeptide is a cyclic peptide obtained from Polymyxin B by proteolytic removal of its terminal amino acyl residue. Polymyxin B nonapeptide is less toxic, lacks bactericidal activity, and retains its ability to render gram-negative bacteria susceptible to several antibiotics by permeabilizing their outer membranes.
    Polymyxin B nonapeptide
  • HY-N6708
    Alamethicin 27061-78-5 ≥99.0%
    Alamethicin, isolated from Trichoderma viride, is a channel-forming peptide antibiotic and induces voltage-gated conductance in model and cell membranes.
    Alamethicin
  • HY-106783A
    Polymyxin B nonapeptide TFA 2220175-42-6 99.82%
    Polymyxin B nonapeptide TFA is a cyclic peptide obtained from Polymyxin B by proteolytic removal of its terminal amino acyl residue. Polymyxin B nonapeptide TFA is less toxic, lacks bactericidal activity, and retains its ability to render gram-negative bacteria susceptible to several antibiotics by permeabilizing their outer membranes.
    Polymyxin B nonapeptide TFA
  • HY-P2322
    Iturin A 52229-90-0 98.53%
    IturinA exhibits strong antifungal activity against pathogenic yeast and fungi. Iturin A interacts with the cytoplasmic membrane of the target cell forming ion conducting pores.
    Iturin A
  • HY-P1674A
    Murepavadin TFA 99.83%
    Murepavadin (POL7080) (TFA), a 14-amino-acid cyclic peptide, is a highly potent, specific antibiotic. Murepavadin exhibits a potent antimicrobial activity for P. aeruginosa with MIC50 and MIC90 values both of 0.12 mg/L. Murepavadin also can target the lipopolysaccharide transport portin D. Murepavadin can be used for the research of bacterial resistance.
    Murepavadin TFA
  • HY-P1222B
    LL-37, human acetate 99.71%
    LL-37, human acetate is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity. LL-37, human acetate could help protect the cornea from infection and modulates wound healing.
    LL-37, human acetate
  • HY-P1649B
    SPR741 acetate 99.55%
    SPR741 acetate (NAB741 acetate) is a cationic peptide derived from polymyxin B and is a potentiator molecule. SPR741 acetate increases the permeability of the outer membrane of Gram-negative bacteria and is used to treat severe Gram-negative bacteria infections. SPR741 acetate inhibits multidrug-resistant Gram-negative bacteria. The spectrum of activity of the antibiotic can be widened when used in combination with SPR741 acetate.
    SPR741 acetate